首页 | 本学科首页   官方微博 | 高级检索  
检索        

门冬胰岛素30治疗2型糖尿病疗效观察
引用本文:孙伟,朱江,徐勉.门冬胰岛素30治疗2型糖尿病疗效观察[J].蚌埠医学院学报,2010,35(1):35-36.
作者姓名:孙伟  朱江  徐勉
作者单位:安徽省淮北市人民医院,内分泌科,235000;昆明医学院附属第二医院,内分泌科,云南,昆明,650032
摘    要:目的:观察胰岛素类似物门冬胰岛素30治疗血糖控制较差的2型糖尿病患者的临床疗效、安全性及耐受性。方法:将40例2型糖尿病患者随机分为两组,B组于早、晚餐前30 min注射预混人胰岛素30R,A组于早、晚餐时注射门冬胰岛素30,药物剂量根据血糖高低调整,比较治疗后两组空腹血糖、餐后血糖、血糖达标时间、胰岛素用量、发生低血糖时血糖值。结果:门冬胰岛素30和预混人胰岛素30R两组均可有效降低血糖(P〈0.01),降糖效果差异无统计学意义(P〉0.05),门冬胰岛素30组发生低血糖时血糖值高于预混人胰岛素30R组(P〈0.05),尤其是夜间严重低血糖水平的发生。结论:在2型糖尿病患者中应用门冬胰岛素30降糖效果显著,安全性高,患者耐受性和依从性好。

关 键 词:糖尿病  2型  门冬胰岛素30  预混人胰岛素30R

Clinical study on insulin analogue aspart 30 in the treatment of type 2 diabetes mellitus
SUN Wei,ZHU Jiang,XU Mian.Clinical study on insulin analogue aspart 30 in the treatment of type 2 diabetes mellitus[J].Journal of Bengbu Medical College,2010,35(1):35-36.
Authors:SUN Wei  ZHU Jiang  XU Mian
Institution:1.Department of Endocrinology,Huaibei People′s Hospital,Huaibei Anhui 235000;2.Department of Endocrinology,The Second Affiliated Hospital of Kunming Medical College,Kunming Yunnan 650032,China)
Abstract:Objective:To observe the clinical therapeutic effects,safety and resistance of insulin analogue aspart 30 in treatment for type 2 diabetes mellitus.Methods:Forty patients with type 2 diabetes mellitus.were randomly divided into A group and B group,aspart 30 was used in A group patients while novolin 30R was used in B group patients,A group and B group patients were treated twice daily in morning and evening respectively.And the drug doses were adjusted momentarily according to the concentration of blood glu...
Keywords:diabetes mellitus  type 2  aspart 30  novolin 30R  
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号